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SUMMARY
This thesis deals with the optimization of quantitative receptor assays (QRA) of
anticholinergic drugs. QRA have recently emerged as a new tool in bioanalysis, offering
challenging perspectives with regard to improving sensitivities and/or selectivities. Similar
to immunoassays, QRA is a binding assay in which an analyte and a (radio)labelled ligand
compete for the binding to a specific protein. In immunoassays the latter are antibodies
raised against a given antigen. Yet, in QRA the specific protein is the isolated receptor
with which the analyte interacts when exerting its pharmacological effect in vivo.
Chapter I in detail describes the state of the art of QRA. The factors influencing the
analytical characteristics of QRA and the approach to their optimization are discussed.
The review also points out the main directions in improving QRA by using the purified
and solubilized receptor. In order to allow a wide-spread use of these assays in routine
(clinical) practice, the development of solid-phase assays seems highly desirable.
Chapter 2 presents a fwo-step purification procedure for the muscarinic receptor from
calf striatum for the purpose of QRA. This procedure includes the extraction of lipids
with hexane in the first step and the removal of non-receptor proteins in the second step
by means of 2 M sodium chloride. In order to check the influence of the purification on
the ligand binding properties of the muscarinic receptor, two different types of labelled
ligand, the tertiary amine 3H-dexetimide (3H-DEX) and the quaternary amine 3H-N-
methylscopolamine (3H-NMS) were used.
Such a combination of the receptor material (purified or non-purified) and labelled
ligand was sought, which gave the best results with regard to high affinity, the ratio speci-
fic/non-specific binding and lack of plasma interference. The high affinity of binding was
preserved for both ligands for all the membrane-bound receptor preparations, which
makes the purification procedure suitable for the purpose of solid-phase RA. No signifi-
cant improvement was achieved in the ratio specific/non-specific binding, neither for 3H-
DEX, nor for 3H-NMS by puriffing muscarinic receptors with hexane. However, the use
of the NaCl-pellet in combination with hydrophilic 3H-NMS appeared to be preferable
over non-purified receptors, since receptor density per mg protein increased by a factor of
about 1.7. This improves the counting precision in the assay. Also, the overall yield of
receptors in the NaCl-pellet was higher when measured with 3H-NMS (S\Vo) than that
measured with 3H-DEX (40%). Thus, rather than in absolute terms, the improvement of
the receptor material has to be considered by also taking into account the different
physico-chemical properties of the labelled ligands. The use of the hydrophilic 3H-NMS
over the lipophilic 3H-DEX in combination with the NaCl-pellet was considered prefera-
ble because of the higher ratio specific/non-specific binding and the negligible interference
of plasma.
In Chapter 3, the possibilities to prepare solubilized muscarinic receptors with pre-
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served binding properties for anticholinergics were studied. Also, the impact of optimizing
the purification and solubilization procedure was evaluated. The factors addressed
included the amounts of protein and digitonin introduced in the procedure and the time
and temperature of the solubilization. The improvements achieved by first purifying and
then solubilizing made this approach preferable over direct solubilization of non-purified
receptor material. The treatment of purified receptors with digitonin preserved the high
affinity for 3H-NMS (& - 0.645 nM), while the solubilization of non-purified receptor
resulted in increased Ko-value (Ka = 2.422 nM). Also, the receptor density in the prepa-
ration solubilized after the purification was higher than that in non-purified solubilized
material by a factor of about 1.7. The solubilized receptor can be used in the direct assay
of plasma samples without any interfering effect on 3H-DEX binding to the muscarinrc
receptor. When purified membrane-bound receptors were used, plasma appeared to sub-
stantially interfere with 3H-DEX bincling.
With regard to the choice of the appropriate labelled l igand, the results obtained in
Chapter 2 with the membrane-bound receptor were similar for the solubilized receptor.
Also for the solubilized receptor 3H-NMS was distinctly preferable over 3H-DEX. Using3H-NMS, the percentage of non-specific binding dropped and the ratio specific/non-
specific binding increased by a factor of about 20, when compared to the membrane-
bound receptor.
The study presented in Chapter 4 was initiated by our observation that, by using the
solubilized receptor, the detrimental effect of plasma on 3H-DEX binding can be avoided.
In this chapter the factors involved in this effect were studied in more detail. Two of
them, the amount of the digitonin-solubilized receptor in the assay and the temperature,
appeared to be critical. Apparently, the presence of digitonin together with the solubilized
receptor is of key importance, since avoidance of interference could not be obtained by
the addition of digitonin to the assay with the membrane-bouncl receptor. AJso, an
interesting observation was made about the restoring effect of plasma on digitonin-
inhibited ligand binding to the muscarinic receptor observed during the solubilization. The
nature of the plasma components responsible for the latter effect is discussed. Our results
suggest a synergistic effect of digitonin and plasma in preventing and overcoming the
inhibitory effect that each of them have when present alone.
Chapter 5 deals with the impact of purification and solubilization of receptor material
on the receptor assays of selected anticholinergic drugs. In Chapters 2 and 3, the im-
provements achieved by purification and solubilization were considered in terms of the
labelled ligand binding only. Here, the different receptor preparations were evaluated in
the assay system. Two different analytes, the tertiary amine scopolamine and the
quaternary amine oryphenonium, were tested. 3H-NMS, which had turned out to be
preferable orrer 3H-DEX for both the membrane-bound and the solubilized receptor, was
used as the labelled ligand.
The Ko-values for both anticholinergics calculated from inhibition studies with 3H-NMS
were similar for all the membrane-bound receptor preparations, either in absence or
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presence of plasma. When the optimum amount of solubil ized proteins/digitonin was
used, a gain in sensitivity for scopolamine by a factor of 1.5 - 2.8 in plasma could be
achieved. In case of oryphenonium, a dramatic loss in sensitivity on the basis of Ko was
observed for the solubilized receptor. Interestingly, this loss could be offset partially when
the assay was performed in the presence of plasma. Our results suggest that for every
individual anticholinergic drug the conditions used have to be carefully chosen, especially
when the RA is performed with solubilized receptors.
In Chapter 6 some final remarks about the importance of the results obtained are
made. In view of the consequences of the purification and solubilization for applications
in practice, we have clear indications that solubilized receptors are preferable over
membrane-bound receptors in direct plasma assays.
The presented results are discussed here with regard to the application of different
receptor materials for solid-phase RA with immobilized receptors. The possibilities of
using the purified and the solubilized receptor in developing new RA, especially solid-
phase RA and non-isotopic RAn are outlined.
